CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D014029: Tobacco Use Disorder NIH

(Synonyms: Tobacco Use Disorder)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1486 Web + text smoking cessation intervention Wiki 1.00

Correlated MeSH Terms (0)


Name (Synonyms) Correlation

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Improving Smoking Cessation in Socioeconomically-Disadvantaged Young Adults

The purpose of this study is to understand how to develop and deliver a better smoking cessation program for lower-income young adult smokers.

NCT04379388 Nicotine Dependence, Cigarettes Behavioral: Web + text smoking cessation intervention
MeSH:Tobacco Use Disorder

Primary Outcomes

Description: Self-reported smoking abstinence and biochemical validation (saliva cotinine)

Measure: 30-day point prevalence smoking abstinence

Time: Assessed at 3-month follow-up

Description: Confidence to quit within the next month (7days) on 0-10 scale

Measure: Self-efficacy to quit smoking

Time: Assessed at 3-month follow-up

Description: Completing 75% or more of 12 weekly check-ins

Measure: Intervention engagement

Time: 12 weeks

Secondary Outcomes

Description: Self-reported smoking abstinence

Measure: 7-day point prevalence smoking abstinence

Time: Assessed at 3-month follow-up

Description: Number of times intentionally stopped smoking cigarettes for 24 hours or longer because trying to quit

Measure: Number of 24-hour quit attempts

Time: Assessed at 3-month follow-up

Description: 4 items pertaining to quit support from the text messages

Measure: Perceived support to quit smoking

Time: Assessed 3-month follow-up

Description: Past 30 (90 day) use of tobacco or nicotine products such as cigars, e-cigarettes, chewing tobacco, and nicotine replacement products

Measure: Pattern and rate of tobacco/e-cigarette use

Time: Assessed at 3-month follow-up


HPO Nodes